ERT Enables Clinical Trial Continuity through At-Home Respiratory Solutions

ERT's At-Home Respiratory Solutions enable clinical trial sponsors to continue developing new respiratory treatments while patient access to investigative sites is limited due to COVID-19 stay-at-home mandates.